Human Cathelicidin, HCAP-18, is Processed to the Antimicrobial Peptide LL-37 by Extracellular Cleavage with Proteinase 3
Overview
Affiliations
Cathelicidins are a family of antimicrobial proteins found in the peroxidase-negative granules of neutrophils. The known biologic functions reside in the C-terminus, which must be cleaved from the holoprotein to become active. Bovine and porcine cathelicidins are cleaved by elastase from the azurophil granules to yield the active antimicrobial peptides. The aim of this study was to identify the physiological setting for cleavage of the only human cathelicidin, hCAP-18, to liberate the antibacterial and cytotoxic peptide LL-37 and to identify the protease responsible for this cleavage. Immunoelectron microscopy demonstrated that both hCAP-18 and azurophil granule proteins were present in the phagolysosome. Immunoblotting revealed no detectable cleavage of hCAP-18 in cells after phagocytosis. In contrast, hCAP-18 was cleaved to generate LL-37 in exocytosed material. Of the 3 known serine proteases from azurophil granules, proteinase 3 was solely responsible for cleavage of hCAP-18 after exocytosis. This is the first detailed study describing the generation of a human antimicrobial peptide from a promicrobicidal protein, and it demonstrates that the generation of active antimicrobial peptides from common proproteins occurs differently in related species. (Blood. 2001;97:3951-3959)
Svensson D, Nilsson B Inflamm Res. 2025; 74(1):36.
PMID: 40063262 PMC: 11893641. DOI: 10.1007/s00011-025-02005-8.
A short review: the biological activity of vitamin D and its decomposition products.
Shimomura H, Wanibuchi K, Hosoda K, Amgalanbaatar A, Shoji M, Hayashi S Mol Biol Rep. 2025; 52(1):214.
PMID: 39921794 DOI: 10.1007/s11033-025-10322-8.
Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation.
Dzurova L, Holaskova E, Pospisilova H, Schneider Rauber G, Frebortova J Antibiotics (Basel). 2025; 14(1).
PMID: 39858288 PMC: 11762488. DOI: 10.3390/antibiotics14010001.
Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation.
Popa A, Gherasim A, Caba L, Nita O, Graur M, Mihalache L Metabolites. 2024; 14(12).
PMID: 39728453 PMC: 11676726. DOI: 10.3390/metabo14120672.
Harmon T, Song J, Gulewicz A, Di Y, Horne W, Seth Horne W Chembiochem. 2024; 26(5):e202400951.
PMID: 39714882 PMC: 11875557. DOI: 10.1002/cbic.202400951.